Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Sprout Health vs Kongo

Sprout Health
Graded #12

Higher grade

vs+2
Kongo
Graded #21

Lower grade

The verdict

Sprout Health takes it — 86/100 to 84/100, but only just.

Sprout Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start. Kongo is close behind and may still be the better fit — see the factor split below.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSprout Health +4
90
86
Dose & formulationSprout Health +2
82
80
Clinical oversightSprout Health +4
88
84
Labs & monitoringSprout Health +10
92
82
FulfillmentKongo +9
78
87
Contract termsKongo +1
84
85
Sprout Health · left barKongo · right bar

The numbers

MetricSprout HealthKongo
WeighScore86/10084/100
GradeBB
Scorecard rank#12#21
Semaglutide$149/mo$119/mo
Tirzepatide$199/mo$229/mo
CoverageNot disclosedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Sprout Health

Graded #12 · B

Strengths

  • LegitScript-certified with a listed address and contact line
  • Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
  • Low-friction intake — no labs and often no telehealth visit required

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved
  • No oral or sublingual route — injectable only
  • Thin transparency — no named medical director, and state availability is quiz-gated
  • "No labs, no visit" convenience also means lighter clinical oversight
Kongo

Graded #21 · B

Strengths

  • $119 semaglutide
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Tirzepatide jumps to $229/mo
  • Injection-only
  • Monitoring detail sparse

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 37 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard